- Home
- MTVA vs CAPT Comparison
MTVA vs CAPT Comparison
Compare MTVA & CAPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTVA
- CAPT
- Stock Information
- Founded
- MTVA 2014
- CAPT 2005
- Country
- MTVA United States
- CAPT South Korea
- Employees
- MTVA N/A
- CAPT N/A
- Industry
- MTVA
- CAPT Blank Checks
- Sector
- MTVA
- CAPT Finance
- Exchange
- MTVA NYSE
- CAPT Nasdaq
- Market Cap
- MTVA 15.1M
- CAPT 16.0M
- IPO Year
- MTVA N/A
- CAPT N/A
- Fundamental
- Price
- MTVA $0.69
- CAPT $1.23
- Analyst Decision
- MTVA Strong Buy
- CAPT
- Analyst Count
- MTVA 2
- CAPT 0
- Target Price
- MTVA $7.50
- CAPT N/A
- AVG Volume (30 Days)
- MTVA 599.8K
- CAPT 2.0M
- Earning Date
- MTVA 05-14-2025
- CAPT 01-01-0001
- Dividend Yield
- MTVA N/A
- CAPT N/A
- EPS Growth
- MTVA N/A
- CAPT N/A
- EPS
- MTVA N/A
- CAPT N/A
- Revenue
- MTVA N/A
- CAPT $17,389,944.00
- Revenue This Year
- MTVA N/A
- CAPT N/A
- Revenue Next Year
- MTVA N/A
- CAPT N/A
- P/E Ratio
- MTVA N/A
- CAPT N/A
- Revenue Growth
- MTVA N/A
- CAPT 84.70
- 52 Week Low
- MTVA $0.63
- CAPT $0.37
- 52 Week High
- MTVA $5.30
- CAPT $3.57
- Technical
- Relative Strength Index (RSI)
- MTVA N/A
- CAPT 64.70
- Support Level
- MTVA N/A
- CAPT $0.97
- Resistance Level
- MTVA N/A
- CAPT $1.63
- Average True Range (ATR)
- MTVA 0.00
- CAPT 0.18
- MACD
- MTVA 0.00
- CAPT 0.09
- Stochastic Oscillator
- MTVA 0.00
- CAPT 67.63
About MTVA METAVIA INC
MetaVia Inc is a clinical-stage biotechnology company focused on developing novel pharmaceuticals to treat cardiometabolic diseases. It has two programs focused on the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and obesity. DA-1241 is a novel G-Protein-Coupled Receptor 119 (GPR119) agonist with development optionality as a standalone and/or combination therapy for both MASH and Type 2 Diabetes Mellitus (T2DM). DA-1726 is a novel oxyntomodulin (OXM) analogue functioning as a GLP-1 receptor (GLP1R) and glucagon receptor (GCGR) dual agonist for the treatment of obesity that is designed to be administered once weekly subcutaneously.
About CAPT Captivision Inc.
Captivision Inc Formerly Glaam Co Ltd is engaged in manufacturing, installing, and selling LED display G-Glass. G-Glass is an integrated ICT product that has the basic characteristics of transparent glass but can display media images at the same time. It implements media images through the glass surface while preserving the features of clear and transparent glass. G-Glass is the world's first IT building material that can be applied to various places where glass is used.